TY - JOUR
T1 - Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome
AU - Tavcar, Jovana
AU - Movilla, Peter
AU - Carusi, Daniela A.
AU - Loring, Megan
AU - Reddy, Himabindu
AU - Isaacson, Keith
AU - Morris, Stephanie N.
N1 - Funding Information:
The authors thank Joyce Wang, BA, Jennifer Wang, MS, Blanca Morales, MD, and Alexandria Williams, MD, for telephone survey and data entry, and Mollie O'Brien, BA, for statistical analysis and graphical displays.
Publisher Copyright:
© 2022 AAGL
PY - 2023/3
Y1 - 2023/3
N2 - Study Objective: To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS). Design: This is a retrospective cohort study, conducted through a telephone survey and chart review. Setting: Minimally invasive gynecologic surgery center in an academic community hospital. Patients: Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications. Interventions: Telephone survey. Measurements and Main Results: We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion. Conclusion: There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.
AB - Study Objective: To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS). Design: This is a retrospective cohort study, conducted through a telephone survey and chart review. Setting: Minimally invasive gynecologic surgery center in an academic community hospital. Patients: Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications. Interventions: Telephone survey. Measurements and Main Results: We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion. Conclusion: There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.
KW - Abnormal placentation
KW - Hysteroscopy
KW - Intrauterine adhesions
UR - http://www.scopus.com/inward/record.url?scp=85144285686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144285686&partnerID=8YFLogxK
U2 - 10.1016/j.jmig.2022.11.013
DO - 10.1016/j.jmig.2022.11.013
M3 - Article
C2 - 36442752
AN - SCOPUS:85144285686
SN - 1553-4650
VL - 30
SP - 192
EP - 198
JO - Journal of Minimally Invasive Gynecology
JF - Journal of Minimally Invasive Gynecology
IS - 3
ER -